SCHEMBL7803141

SCHEMBL7803141

NC1=C(C2=CCCCCC2)CCCCC1

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
JAK3 P52333 1/20 0.33
HDAC1 Q13547 3/20 0.33
HDAC2 Q92769 3/20 0.33
TYMP P19971 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM1A O60341 1/20 0.32
HDAC3 O15379 2/20 0.32
FFAR4 Q5NUL3 1/20 0.31
ATR Q13535 1/20 0.31
ELANE P08246 1/20 0.31
ACMSD Q8TDX5 1/20 0.31
PTPN11 Q06124 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9887300 0.86
SCHEMBL3502363 0.75 TYMP (0.41) ALDH1A1CYP3A4JAK2JAK1JAK3
SCHEMBL2105114 0.75 TYMP (0.41) ALDH1A1CYP3A4JAK2JAK1JAK3
SCHEMBL18244172 0.75 TYMP (0.41) ALDH1A1CYP3A4JAK2JAK1JAK3
SCHEMBL18244171 0.75 TYMP (0.41) ALDH1A1CYP3A4JAK2JAK1JAK3
SCHEMBL3233362 0.75 TYMP (0.41) ALDH1A1CYP3A4JAK2JAK1JAK3
SCHEMBL21057468 0.75 TYMP (0.41) ALDH1A1CYP3A4JAK2JAK1JAK3
SCHEMBL3233355 0.75 TYMP (0.41) ALDH1A1CYP3A4JAK2JAK1JAK3
SCHEMBL11201526 0.75 TYMP (0.41) ALDH1A1CYP3A4JAK2JAK1JAK3
SCHEMBL3796623 0.75 TYMP (0.41) ALDH1A1CYP3A4JAK2JAK1JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1385422-A Process for preparing 2-azadihydroxybicyclo [2.2.1] heptane compounds AVENTIS PHARMA INC (US) 2002-12-18 CN disclosed
CN-1094927-C Process for preparing 2-azadihydroxybicyclo [2.2.1] heptane compounds and L-tartrate salts of such compounds AVENTIS PHARMACEUTICAL CORP (US) 2002-11-27 CN disclosed
EP-0934268-A4 PROCESS FOR PREPARING 2-AZADIHYDROXYBICYCLO 2.2.1]HEPTANE COMPOUNDS AND THE L-TARTARIC ACID SALT OF THE COMPOUND RHONE POULENC RORER PHARMA (US) 2001-04-18 EP disclosed
CN-1233239-A Process for preparing 2-azadihydroxybicyclo [2.2.1] heptane compounds and L-tartrate salts of such compounds RHONE POULENC RORER PHARMA (US) 1999-10-27 CN disclosed
EP-0934268-A1 PROCESS FOR PREPARING 2-AZADIHYDROXYBICYCLO 2.2.1]HEPTANE COMPOUNDS AND THE L-TARTARIC ACID SALT OF THE COMPOUND RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-08-11 EP disclosed
US-5886192-A L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1!heptane compounds RHONE-POULENC RORER S.A. (FR) 1999-03-23 US disclosed
US-5831096-A L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1! heptane compounds RHONE-POULENC RORER S.A. (FR) 1998-11-03 US disclosed
US-5808093-A L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1!heptane compounds RHONE-POULENC RORER S.A. (FR) 1998-09-15 US disclosed
WO-1998016510-A1 PROCESS FOR PREPARING 2-AZADIHYDROXYBICYCLO[2.2.1]HEPTANE COMPOUNDS AND THE L-TARTARIC ACID SALT OF THE COMPOUND RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-04-23 WO disclosed
US-5684159-A L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1!heptane compounds RHONE-POULENC RORER S.A. (FR) 1997-11-04 US disclosed